Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001047469-16-016312
Filing Date
2016-10-26
Accepted
2016-10-26 17:15:17
Documents
5

Document Format Files

Seq Description Document Type Size
1 424B5 a2230098z424b5.htm 424B5 714217
2 G7385.JPG g7385.jpg GRAPHIC 25754
3 G446477.JPG g446477.jpg GRAPHIC 19756
4 G703692.JPG g703692.jpg GRAPHIC 158945
5 G793848.JPG g793848.jpg GRAPHIC 141485
  Complete submission text file 0001047469-16-016312.txt   1192299
Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Filer) CIK: 0001583107 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-214257 | Film No.: 161953308
SIC: 2834 Pharmaceutical Preparations